Pegasys — Medica
Recurrent Hepatitis C Virus (HCV) Post-Liver Transplantation, Pediatric and Adolescent (≥ 2 Years and ≤ 17 Years of Age)
Initial criteria
- age ≥ 2 years and < 17 years
- medication is prescribed in combination with ribavirin unless there is a contraindication or intolerance to ribavirin according to the prescriber
- medication is prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or liver transplant physician affiliated with a transplant center
Approval duration
48 weeks